2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow eluforsen: new trials by email Literature Review of eluforsen trials Research Report on eluforsen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation QR-010 - Cystic Fibrosis | Phase 1 | Completed | ProQR Therapeutics | 18 | 2015-09-01 | 2020-09-24 |
| Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients QR-010, Placebo - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | ProQR Therapeutics | 70 | 2015-06-01 | 2019-02-06 |
Cystic Fibrosis (2)
Belgium (2) · France (2) · United States (2) · Canada (1) · Czechia (1) · Denmark (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)
John P Clancy, MD (1) · Stuart Elborn, MD (1)